No Data
No Data
Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday?
Hong Kong Stock Concept Tracking | Jiangsu Hengrui Pharmaceuticals and Merck have reached a licensing agreement, significantly enhancing the "gold content" of Hong Kong Stock Innovative Drugs (with concept stocks attached).
Sinolink released a Research Report stating that the "valuation expansion elasticity and space" of Hong Kong's Innovative Drugs may be stronger than that of A-shares.
Citi Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $115
Gamestop, FST Corp, Merck, UPS, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Jiangsu Hengrui Pharmaceuticals signed a licensing agreement for the HRS-5346 project with Merck (MRK.US).
According to the agreement, Merck (MRK.US) will acquire exclusive rights to develop, produce, and commercialize HRS-5346 globally outside of Greater China.
Is Merck & Co. Inc. (MRK) The Best Defensive Stock Amid Market Volatility?
Unlock the Full List